Christopher J O'Donnell (Christopher O'Donnell)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

Journal of medicinal chemistry

Molecular cancer therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Pettersson, Douglas S Johnson, John M Humphrey, Christopher W Am Ende, Todd W Butler, Peter H Dorff, Ivan V Efremov, Edelweiss Evrard, Michael E Green, Christopher J Helal, Gregory W Kauffman, Patrick B Mullins, Thayalan Navaratnam, Christopher J O'Donnell, Theresa J O'Sullivan, Nandini C Patel, Antonia F Stepan, Cory M Stiff, Chakrapani Subramanyam, Patrick Trapa, Tuan P Tran, Beth Cooper Vetelino, Eddie Yang, Longfei Xie, Leslie R Pustilnik, Stefanus J Steyn, Kathleen M Wood, Kelly R Bales, Eva Hajos-Korcsok, Patrick R Verhoest
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease. Journal of medicinal chemistry 67 (12) (2024)
Martin Pettersson, Douglas S Johnson, John M Humphrey, Christopher W Am Ende, Todd W Butler, Peter H Dorff, Ivan V Efremov, Edelweiss Evrard, Michael E Green, Christopher J Helal, Gregory W Kauffman, Patrick B Mullins, Thayalan Navaratnam, Christopher J O'Donnell, Theresa J O'Sullivan, Nandini C Patel, Antonia F Stepan, Cory M Stiff, Chakrapani Subramanyam, Patrick Trapa, Tuan P Tran, Beth Cooper Vetelino, Eddie Yang, Longfei Xie, Leslie R Pustilnik, Stefanus J Steyn, Kathleen M Wood, Kelly R Bales, Eva Hajos-Korcsok, Patrick R Verhoest
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease. Journal of medicinal chemistry (2024)
Martin Pettersson, Douglas S Johnson, John M Humphrey, Christopher W Am Ende, Todd W Butler, Peter H Dorff, Ivan V Efremov, Edelweiss Evrard, Michael E Green, Christopher J Helal, Gregory W Kauffman, Patrick B Mullins, Thayalan Navaratnam, Christopher J O'Donnell, Theresa J O'Sullivan, Nandini C Patel, Antonia F Stepan, Cory M Stiff, Chakrapani Subramanyam, Patrick Trapa, Tuan P Tran, Beth Cooper Vetelino, Eddie Yang, Longfei Xie, Leslie R Pustilnik, Stefanus J Steyn, Kathleen M Wood, Kelly R Bales, Eva Hajos-Korcsok, Patrick R Verhoest
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease. Journal of medicinal chemistry 67 (12) (2024)
Emma L McInturff, Scott P France, Carolyn A Leverett, Andrew C Flick, Erick A Lindsey, Simon Berritt, Daniel W Carney, Jacob C DeForest, Hong X Ding, Sarah J Fink, Tony S Gibson, Kaitlyn Gray, Aran K Hubbell, Amber M Johnson, Yiyang Liu, Subham Mahapatra, Indrawan J McAlpine, Rebecca B Watson, Christopher J O'Donnell
Synthetic Approaches to the New Drugs Approved During 2021. Journal of medicinal chemistry (2023)
Andrew C Flick, Carolyn A Leverett, Hong X Ding, Emma L McInturff, Sarah J Fink, Subham Mahapatra, Daniel W Carney, Erick A Lindsey, Jacob C DeForest, Scott P France, Simon Berritt, Simone V Bigi-Botterill, Tony S Gibson, Rebecca B Watson, Yiyang Liu, Christopher J O'Donnell
Synthetic Approaches to the New Drugs Approved During 2020. Journal of medicinal chemistry 65 (14) (2022)
Andrea T Hooper, Kimberly Marquette, Chao-Pei Betty Chang, Jonathon Golas, Sadhana Jain, My-Hanh Lam, Magali Guffroy, Mauricio Leal, Hadi Falahatpisheh, Divya Mathur, Ting Chen, Kerry Kelleher, Kiran Khandke, Elwira Muszynska, Frank Loganzo, Edward Rosfjord, Judy Lucas, Zhengyan Kan, Chakrapani Subramanyam, Christopher J O'Donnell, Dario Neri, Hans-Peter Gerber, Chad May, Puja Sapra
Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade. Molecular cancer therapeutics 21 (9) (2022)
Andrew C Flick, Carolyn A Leverett, Hong X Ding, Emma L McInturff, Sarah J Fink, Subham Mahapatra, Daniel W Carney, Erick A Lindsey, Jacob C DeForest, Scott P France, Simon Berritt, Simone V Bigi-Botterill, Tony S Gibson, Yiyang Liu, Christopher J O'Donnell
Synthetic Approaches to the New Drugs Approved during 2019. Journal of medicinal chemistry 64 (7) (2021)
Yoon-Chi Han, Jennifer Kahler, Nicole M Piche-Nicholas, Wenyue Hu, Stephane Thibault, Fan Jiang, Mauricio Leal, Madan Katragadda, Andreas Maderna, Russell Dushin, Nadira Prashad, Manoj B Charati, Tracey Clark, L Nathan Tumey, Xingzhi Tan, Andreas Giannakou, Edward Rosfjord, Hans-Peter Gerber, Lioudmila Tchistiakova, Frank Loganzo, Christopher J O'Donnell, Puja Sapra
Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Edmund I Graziani, Matthew Sung, Dangshe Ma, Bitha Narayanan, Kimberly Marquette, Sujiet Puthenveetil, L Nathan Tumey, Jack Bikker, Jeffrey Casavant, Eric M Bennett, Manoj B Charati, Jonathon Golas, Christine Hosselet, Cynthia M Rohde, George Hu, Magali Guffroy, Hadi Falahatpisheh, Martin Finkelstein, Tracey Clark, Frank Barletta, Lioudmila Tchistiakova, Judy Lucas, Edward Rosfjord, Frank Loganzo, Christopher J O'Donnell, Hans-Peter Gerber, Puja Sapra
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers. Molecular cancer therapeutics 19 (10) (2020)
Andrew C Flick, Carolyn A Leverett, Hong X Ding, Emma L McInturff, Sarah J Fink, Christopher J Helal, Jacob C DeForest, Peter D Morse, Subham Mahapatra, Christopher J O'Donnell
Synthetic Approaches to New Drugs Approved during 2018. Journal of medicinal chemistry 63 (19) (2020)
Andrew C Flick, Carolyn A Leverett, Hong X Ding, Emma McInturff, Sarah J Fink, Christopher J Helal, Christopher J O'Donnell
Synthetic Approaches to the New Drugs Approved During 2017. Journal of medicinal chemistry 62 (16) (2019)
Christopher J Helal, Eric Arnold, Tracey Boyden, Cheng Chang, Thomas A Chappie, Ethan Fisher, Mihaly Hajos, John F Harms, William E Hoffman, John M Humphrey, Jayvardhan Pandit, Zhijun Kang, Robin J Kleiman, Bethany L Kormos, Che-Wah Lee, Jiemin Lu, Noha Maklad, Laura McDowell, Dina McGinnis, Rebecca E O'Connor, Christopher J O'Donnell, Adam Ogden, Mary Piotrowski, Christopher J Schmidt, Patricia A Seymour, Hirokazu Ueno, Nichole Vansell, Patrick R Verhoest, Edward X Yang
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate. Journal of medicinal chemistry 61 (3) (2018)
Andrew C Flick, Hong X Ding, Carolyn A Leverett, Sarah J Fink, Christopher J O'Donnell
Synthetic Approaches to New Drugs Approved During 2016. Journal of medicinal chemistry 61 (16) (2018)
Andrew C Flick, Hong X Ding, Carolyn A Leverett, Robert E Kyne, Kevin K-C Liu, Sarah J Fink, Christopher J O'Donnell
Synthetic Approaches to the New Drugs Approved During 2015. Journal of medicinal chemistry 60 (15) (2017)
Andrew C Flick, Hong X Ding, Carolyn A Leverett, Robert E Kyne, Kevin K-C Liu, Sarah J Fink, Christopher J O'Donnell
Correction to Synthetic Approaches to the New Drugs Approved During 2015. Journal of medicinal chemistry 60 (20) (2017)

Christopher J O'Donnell.css-eqlu8i{font-size:small;padding-left:4px;} (Christopher O'Donnell)

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher J O'Donnell (Christopher O'Donnell)